Company intelligence / Profile preview

Mitos Pharmaceuticals, Inc.

Not specified, California*, United Statesbiopharmguy.com ↗

Ownership: Private
Development stage: Other

Overview

Mitos Pharmaceuticals, Inc. is a private pharmaceutical company based in California focused on developing small molecule therapeutics. Its lead candidate is Tempol, which targets hypoxia-inducible factor pathways and reactive oxygen species. The most advanced clinical program has reached Phase III for radiodermatitis and previously targeted alopecia in Phase II trials. There are two clinical trials associated with the company; one for prevention of alopecia induced by whole brain radiotherapy had an unknown status as of early 2025.

Therapeutic areas: Dermatology
Modalities: Small molecules (e.g., Tempol)
Industry: Biotech

Beyond the preview

Go deeper on Mitos Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitos Pharmaceuticals, Inc..

Explore the full profile